ITEM 8. FINANCIAL STATEMENTS AND SCHEDULES
The report of our Independent Public Accountants, Consolidated
Financial Statements and Notes to Consolidated Financial Statements appears
herein commencing on page F-1. Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Not applicable.                    17 ILEX ONCOLOGY, INC.
2001 ANNUAL REPORT ON FORM 10-K
- 
PART II. Item 5. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The information called for by item 10 of Form 10-K is incorporated
herein by reference to such information included in our Proxy Statement for the
2002 Annual Meeting of Stockholders.
